⚠ Cardinal Rule: Treat unknown or uncertain vaccination history as ZERO previous doses. Natural tetanus infection does NOT confer immunity; vaccination is required even after recovery from clinical tetanus.
Vaccination History
Clean, Minor Wound
Tetanus-Prone Wound
Unknown or <3 doses
Td/Tdap: YES TIG: No
Td/Tdap: YES TIG: YES (250 IU)
≥3 doses, booster <5 yrs
Td/Tdap: No TIG: No
Td/Tdap: No TIG: No
≥3 doses, booster 5-10 yrs
Td/Tdap: No TIG: No
Td/Tdap: YES TIG: No
≥3 doses, booster >10 yrs
Td/Tdap: YES TIG: No
Td/Tdap: YES TIG: No*
⚠ *Immunocompromised Exception: Patients with HIV/AIDS or severe immunodeficiency who have contaminated wounds should receive TIG regardless of their vaccination history.
Wound Classification: Clean vs Tetanus-Prone
Feature
Clean, Minor
Tetanus-Prone ⚠
Age of wound
<6 hours
>6 hours
Configuration
Linear, sharp edge
Stellate, avulsion, crush, missile
Depth
<1 cm
>1 cm (deep)
Mechanism
Sharp object (knife, glass)
Puncture, crush, burn, frostbite
Contamination
None / minimal
Soil, faeces, saliva, dirt, rust
Tissue viability
Viable, well-perfused
Devitalised, ischaemic, necrotic
Infection
Absent
Signs of infection present
💡 Pearl: If ANY single feature from the tetanus-prone column is present, classify the wound as tetanus-prone. When in doubt, treat as tetanus-prone.
Which Vaccine? Td vs Tdap vs DTaP
Patient Age
Preferred Vaccine
Alternative
<7 years
DTaP (or DTwP in NIS context)
DT if pertussis contraindicated
7-18 years
Tdap (if never received Tdap)
Td if Tdap previously received or unavailable
≥19 years
Tdap (if never received Tdap)
Td if Tdap previously received
Pregnant
Tdap 27-36 weeks (each pregnancy)
Td if Tdap unavailable
Key Difference: Lowercase letters (d, p) denote reduced antigen content in adult formulations. Paediatric DTaP has 3-4 times more diphtheria toxoid than adult Td.
Tdap Priority: Every adult should receive at least 1 lifetime dose of Tdap. If Tdap status is unknown, use Tdap for wound management rather than Td.
Indian Context: Td replaced TT in the NIS (2019). In government settings, Td is the standard. Tdap availability is primarily in private practice.
Tetanus Immunoglobulin (TIG): The Details
Parameter
Detail
Product
Human TIG (preferred). Equine ATS if human TIG unavailable (higher anaphylaxis risk; requires sensitivity testing).
Dose
250 IU IM for wounds of average severity. 500 IU if wound >24 hours old or heavily contaminated.
Administration
IM injection. When given with Td/Tdap, use separate syringes at different anatomical sites.
Mechanism
Provides immediate passive immunity by neutralising circulating tetanus toxin. Cannot reverse toxin already bound to nerve endings.
Duration
Passive protection only. Patient still requires active immunisation (Td/Tdap) for long-term immunity.
Wound Management: The Surgical Essentials
⚠ Critical: Tetanus prophylaxis (vaccine + TIG) is NOT a substitute for proper wound care. Thorough cleaning and debridement of devitalised tissue is essential.
Irrigation: Copious irrigation with normal saline or clean running water under pressure. Remove all foreign material.
Debridement: Excise devitalised, necrotic, and ischaemic tissue. C. tetani thrives in anaerobic, devitalised tissue.
Closure: Tetanus-prone wounds should generally be left open or closed by delayed primary closure to avoid creating anaerobic conditions.
Antibiotics: Routine antibiotic prophylaxis is NOT indicated solely for tetanus prevention. However, contaminated wounds may warrant antibiotics for polymicrobial infection risk (Metronidazole or Penicillin if clinical tetanus is suspected).
ER Traps & Common Errors
⚠ Sobering Statistic: In a California surveillance study (2008-2014), among tetanus patients who sought medical care for acute injury, only 22% received appropriate prophylaxis. Case-fatality rate remains 13-18% even with modern intensive care.
✗Trap: Giving only TIG without starting active immunisation. TIG provides temporary passive immunity only; the patient remains unprotected long-term.
✗Trap: Assuming "rusty nail" is the only mechanism. Tetanus-prone wounds include garden injuries, animal bites, burns, compound fractures, and even surgical wounds.
✗Trap: Not completing the primary series. If <3 doses have been received, the patient needs a full primary series: dose 2 at ≥4 weeks, dose 3 at 6-12 months after dose 2.
✗Trap: Boosting too frequently. Giving Td boosters at <5 year intervals increases the risk of Arthus-type hypersensitivity reactions.
✓Pearl: Do not restart a vaccine series if doses are delayed. Continue from where the patient left off.
✓Pearl: ~25% of tetanus cases have no identifiable wound or portal of entry. Ensure routine 10-year boosters are up to date.
Tetanus in India: Context
Maternal & Neonatal Tetanus: India was certified for elimination of MNT by WHO in July 2016. However, neonatal tetanus cases continue to be reported (409 cases per HMIS 2021-22).
Adult Tetanus: Cases are primarily in unvaccinated or partially vaccinated elderly agricultural workers. Td vaccine is now given at 10 and 16 years and to pregnant women under NIS.
Diphtheria Resurgence: The shift from TT to Td in 2019 was driven by rising diphtheria cases in older age groups with waning immunity. Td provides dual protection.
Equine ATS Availability: In resource-limited Indian settings where human TIG is unavailable, equine ATS (1,500-3,000 IU IM after sensitivity test) may be used. However, human TIG is strongly preferred due to lower risk of serum sickness.
Special Populations
Population
Key Consideration
Pregnant Women
Td/Tdap is safe. Tdap is preferred at 27-36 weeks (each pregnancy) for passive neonatal pertussis protection. Category C vaccine.
HIV/AIDS
Give TIG for ALL contaminated wounds regardless of vaccination history. Immune response to toxoid may be impaired.
Elderly (≥65 yrs)
Incidence is twice as high as in younger adults (immunosenescence + rural occupation + missed boosters). Ensure 10-year booster compliance.
Infants <6 weeks
No tetanus toxoid vaccine is licensed. Give TIG only for contaminated wounds.
Arthus reaction history
Do not give Td/Tdap booster more frequently than every 10 years. For wound management, give TIG alone if within 10 years of last dose.
Abbreviations: Td (Tetanus & adult Diphtheria toxoid) · Tdap (Tetanus, Diphtheria & acellular Pertussis) · DTaP (Diphtheria, Tetanus & acellular Pertussis, paediatric) · DTwP (Diphtheria, Tetanus & whole-cell Pertussis) · DT (Diphtheria & Tetanus, paediatric) · TT (Tetanus Toxoid) · TIG (Tetanus Immunoglobulin, human) · ATS (Anti-Tetanus Serum, equine) · IU (International Units) · IM (Intramuscular) · NIS (National Immunization Schedule) · ACIP (Advisory Committee on Immunization Practices) · MNT (Maternal & Neonatal Tetanus) · HMIS (Health Management Information System) · CDC (Centers for Disease Control and Prevention) · WHO (World Health Organization)
Algorithm References & Evidence Base
Centers for Disease Control and Prevention (CDC). Clinical Guidance for Wound Management to Prevent Tetanus. CDC; Updated June 2025.
Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the ACIP. MMWR Recomm Rep. 2018;67(No. RR-2):1-44.
World Health Organization. Tetanus vaccines: WHO position paper, February 2017. Wkly Epidemiol Rec. 2017;92(6):53-76.
Ministry of Health and Family Welfare, Government of India. Tetanus and Adult Diphtheria (Td) Operational Guidelines. NHM; 2019.
American Academy of Pediatrics. Red Book: 2024-2027 Report of the Committee on Infectious Diseases. 33rd ed. Itasca, IL: AAP; 2024.
California Department of Public Health. Tetanus Quicksheet. CDPH; February 2025.
Hassel B. Tetanus: Pathophysiology, Treatment, and the Possibility of Using Botulinum Toxin against Tetanus-Induced Rigidity and Spasms. Toxins. 2013;5(1):73-83.
How to Cite This Tool
AMA Style:
Umakanth S. Tetanus Wound Prophylaxis Pathway. MEDiscuss. Published 2026. Accessed .
Vancouver Style:
Umakanth S. Tetanus Wound Prophylaxis Pathway [Internet]. MEDiscuss.org; 2026 [cited ]. Available from: